Effect of acute morphine treatment on peptide levels in the peri-aqueductal grey.
Rosén
A
A
Department of Pharmacology, Karolinska Institute, Stockholm, Sweden.
Brodin
E
E
D000818:Animals; D002766:Cholecystokinin / Q000378:metabolism; D007279:Injections, Subcutaneous; D008297:Male; D009020:Morphine / Q000008:administration & dosage*; D009479:Neuropeptides / Q000378:metabolism*; D009496:Neurotensin / Q000378:metabolism; D010487:Periaqueductal Gray / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D013373:Substance P / Q000378:metabolism
D009479:Neuropeptides; D013373:Substance P; D009496:Neurotensin; D009020:Morphine; D002766:Cholecystokinin